Study of RPT193 in Healthy Adult Male Subjects
NCT06087978
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Male Subjects
Interventions
DRUG:
14C RPT193
Sponsor
RAPT Therapeutics, Inc.